|
|||||
|
|
First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial |
|
| Authors: | Quintero Aldana G. Salgado M. Candamio S. Méndez J. C. Jorge M. Reboredo M. Vázquez Tuñas L. Romero C. Covela M. Fernández Montes A. Carmona M. Vidal Insua Y. López R. |
| Affiliation: | 1.Department of Medical Oncology, Hospital Universitario Lucus Augusti, Calle Doctor Ulises Romero, 1, 27003, Lugo, Spain ;2.Department of Medical Oncology, Complejo Hospitalario Universitario de Ourense, Ourense, Spain ;3.Department of Medical Oncology, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain ;4.Department of Medical Oncology, Centro Oncologico de Galicia, A Coru?a, Spain ;5.Department of Medical Oncology, Complejo Hospitalario Xeral Cíes, Vigo, Spain ;6.Department of Medical Oncology, Complejo Hospitalario Universitario A Coru?a, A Coru?a, Spain ;7.Department of Medical Oncology, Complejo Hospitalario de Pontevedra, Pontevedra, Spain ;8.Department of Medical Oncology, Hospital POVISA, Vigo, Spain ;9.CIBERONC, Madrid, Spain ; |
| Abstract: | Clinical and Translational Oncology - Panitumumab is extensively used for RAS-WT metastatic colorectal cancer. This study assessed the efficacy and safety of panitumumab plus first-line... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |